Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2012
04/10/2012US8153583 Toll like receptor 3 antagonists, methods and uses
04/10/2012US8153582 Personal-care articles having self-assembling peptides
04/10/2012US8153580 Nogo receptor binding protein
04/10/2012US8153398 Polynucleotides encoding signal peptide-containing molecules
04/10/2012US8153360 Flavivirus fusion inhibitors
04/10/2012US8153141 Immunostimulatory G, U-containing oligoribonucleotides
04/10/2012US8153139 Treatment of rosacea with clostridia neurotoxins
04/10/2012US8153133 High potency recombinant antibodies and method for producing them
04/10/2012US8153119 Engineered enzymatically active bacteriophage and methods for dispersing biofilms
04/10/2012US8153115 Virus-like particles for treatment of viral infections
04/10/2012US8153114 Hyperglycosylated mammalian IL-7 IgG conjugate composition
04/10/2012US8153113 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
04/10/2012CA2662967C Medicinal composition
04/10/2012CA2548897C Endoparasiticidal agents for topical application
04/10/2012CA2529575C Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
04/10/2012CA2515080C Methods for preventing mitochondrial permeability transition
04/10/2012CA2486308C Hepatitis c virus inhibitors
04/10/2012CA2477857C Stabilized liquid polypeptide-containing pharmaceutical compositions
04/10/2012CA2468496C Ilk inhibitors for the treatment of renal disease
04/10/2012CA2438921C Streptococcus pyogenes polypeptides and corresponding dna fragments
04/10/2012CA2401032C Memno peptides, a process for their preparation and their use
04/10/2012CA2395713C G-csf conjugates
04/10/2012CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof
04/10/2012CA2353086C Pgc-1, a novel brown fat ppar.gamma. coactivator
04/10/2012CA2352783C Stimulation of t cells against self antigens using ctla-4 blocking agents
04/10/2012CA2352573C Glp-1 analogues
04/10/2012CA2330660C Muscle-derived cell mediated gene delivery for treating muscle-and bone-related injury or dysfunction
04/10/2012CA2302392C Compositions and methods for contraception in or sterilization of mammals
04/05/2012WO2012045083A2 Minimizing intestinal dysfunction
04/05/2012WO2012044939A2 Method of preparing a dry powder from a water bacteria extract-concentrate
04/05/2012WO2012044783A2 Method of achieving a thymosin beta 4 concentration in a human patient
04/05/2012WO2012044745A2 Personal care composition containing yeast extract and hexapeptide
04/05/2012WO2012044684A2 Interferon-beta for use as monotherapy or in combination with other cancer therapies
04/05/2012WO2012044671A2 Method for removing residual organic solvent from microparticles
04/05/2012WO2012043747A1 Glioma treatment method, glioma examination method, method of delivering a desired material to a glioma, and drug used in said methods
04/05/2012WO2012043715A1 Skin collagen production-promoting agent
04/05/2012WO2012043714A1 Skin collagen production-promoting agent
04/05/2012WO2012043713A1 Skin collagen production-promoting agent
04/05/2012WO2012043712A1 Skin collagen production-promoting agent
04/05/2012WO2012043711A1 Skin collagen production-promoting agent
04/05/2012WO2012043688A1 Enteral nutrient
04/05/2012WO2012043577A1 Reversing agent for anticoagulants
04/05/2012WO2012043397A1 Peptide capable of binding to immunoglobulin
04/05/2012WO2012042857A1 Mucosal adjuvant composition
04/05/2012WO2012042540A2 Anticancer agent
04/05/2012WO2012042480A1 Compositions and methods for treatment of hematological malignancies
04/05/2012WO2012042381A1 Composition for controlled ovarian stimulation
04/05/2012WO2012042372A1 Enteric coated, low- strength pancrelipase formulations
04/05/2012WO2012042371A2 Pharmaceutical composition
04/05/2012WO2012042289A1 Methods and pharmaceutical compositions for the treatment of bone density related diseases
04/05/2012WO2012042213A1 Novel interaction between staphylococcus aureus sbi and c3d proteins
04/05/2012WO2012042038A2 Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9
04/05/2012WO2012042037A1 Polypeptides having endopeptidase activity and polynucleotides encoding same
04/05/2012WO2012042023A2 Cyclosporine emulsion
04/05/2012WO2012042021A1 Eph receptor expression in tumor stem cells
04/05/2012WO2012042013A1 Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
04/05/2012WO2012041981A2 Use of growth hormone to enhance the immune response in immunosuppressed patients
04/05/2012WO2012041805A1 N-carboxyalkyl auristatins and the use thereof
04/05/2012WO2012041761A2 Botulinum neurotoxin polypeptides exhibiting a prolonged activity
04/05/2012WO2012041512A1 Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen
04/05/2012WO2012041328A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
04/05/2012WO2012041220A1 Method for purifying cyclic lipopeptide or salt thereof
04/05/2012WO2012040832A1 Immunomodulatory nucleic acid composition comprising chitosan nanoparticles
04/05/2012WO2012020219A3 Formulations for infusion of type b lantibiotics
04/05/2012WO2012012718A3 Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof
04/05/2012WO2012012146A9 Compositions and methods to modulate progression and onset of inflammatory bowel disease
04/05/2012WO2012009715A3 Novel cyclosporin derivatives for the treatment and prevention of a viral infection
04/05/2012WO2012003474A3 Compositions and methods related to protein a (spa) variants
04/05/2012WO2011163462A3 Amide-based insulin prodrugs
04/05/2012WO2011156329A3 Methods of treating pain and morphine tolerance via modulation of hedgehog signalling pathway
04/05/2012WO2011150299A3 Treatment of myocardial infarction and vascular injury with netrin-1
04/05/2012WO2011150279A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
04/05/2012WO2011150073A3 Compositions comprising the nc2 domain of collagen ix and methods of using same
04/05/2012WO2011149955A3 Therapeutic method and composition
04/05/2012WO2011146410A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
04/05/2012WO2011146109A3 Methods and assays for treating subjects with shank3 deletion, mutation or reduced expression
04/05/2012WO2011143482A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
04/05/2012WO2011143317A3 Methods for the regulation of cellular metabolism through the modulation of sirt3 activity
04/05/2012WO2011140274A3 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
04/05/2012WO2011140135A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
04/05/2012WO2011139988A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
04/05/2012WO2011139838A3 Intranasal formulations
04/05/2012WO2011139799A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
04/05/2012WO2011139769A3 Immunogenic compositions and methods for treating neoplasia
04/05/2012WO2011139714A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
04/05/2012WO2011133555A3 Compositions and methods for inhibiting matrix metalloproteinase (mmp)-mediated cell migration
04/05/2012WO2011132943A9 Composition for treatment of acute pseudomembranous colitis
04/05/2012WO2011119009A3 Peptides for promoting angiogenesis and an use thereof
04/05/2012WO2011113036A3 Compositions and methods for expanding bfu-e cells
04/05/2012WO2011112732A3 Methods of treating vascular inflammatory disorders
04/05/2012WO2011109789A3 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
04/05/2012WO2011103382A3 Compositions and methods for inducing angiogenesis
04/05/2012WO2011082087A8 Dps fusion proteins for use in vaccines and diagnostics
04/05/2012US20120083772 Corneal treatment system and method
04/05/2012US20120083588 Neutral amino acid transporter and gene thereof
04/05/2012US20120083587 Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (ma)
04/05/2012US20120083458 Methods and compositions for detecting and treating inflammatory disease
04/05/2012US20120083457 Bortezomib Formulations
04/05/2012US20120083456 Methods of using il-31 to treat chronic obstructive pulmonary disease (copd)
04/05/2012US20120083455 HYMAN SERUM ALBUMIN-siRNA NANO-SIZED CARRIER SYSTEM
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 3163